郑州微飒生物科技有限责任公司 咨询热线:0371-88821766
行业动态

行业动态

追踪行业前沿,洞察产业趋势

药效评价Synthesis and Evaluation of Potent KCNQ2/3-Specific Channel Activators.

期刊:Molecular pharmacology发表年份:2016作者:Manoj Kumar; Nicholas Reed; Ruiting Liu; Elias Aizenman; Peter Wipf; Thanos Tzounopoulos

药效评价Doxorubicin-loaded galactose-conjugated poly(d,l-lactide-co-glycolide) nanoparticles as hepatocyte-targeting drug carrier.

期刊:Journal of microencapsulation发表年份:2016作者:M Margarida Cardoso; Inês N Peça; Cláudia D Raposo; Krasimira T Petrova; M Teresa Barros; Rui Gardner; A Bicho

药效评价Genetic screening reveals a link between Wnt signaling and antitubulin drugs.

期刊:The pharmacogenomics journal发表年份:2016作者:A H Khan; J S Bloom; E Faridmoayer; D J Smith

药效评价Preclinical development of Ramizol, an antibiotic belonging to a new class, for the treatment of Clostridium difficile colitis.

期刊:The Journal of antibiotics发表年份:2016作者:Shasha Rao; Clive A Prestidge; Lynn Miesel; Deb Sweeney; Dean L Shinabarger; Ramiz A Boulos